Trials / Unknown
UnknownNCT05141292
A Registry Study of Biomarkers in Mitral Valve Disease (BIOMS-MVD)
A Registry Study of Biomarkers in Mitral Valve Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- —
Summary
The registry study aims to discover the prognostic value of bio-markers in mitral valve disease
Detailed description
The purpose of this study is to investigate the prognostic value of biomarkers in mitral valve disease.Patients with confirmed diagnosis of mitral valve disease are enrolled.The primary outcome is all-cause mortality based on the death certificates. The secondary outcome is readmission for heart failure and all-cause mortality/readmission for heart failure according to the patients' medical records.
Conditions
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2023-12-31
- Completion
- 2025-12-31
- First posted
- 2021-12-02
- Last updated
- 2022-02-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05141292. Inclusion in this directory is not an endorsement.